Pain/NSAID · General Oral/Topical
SPASOZAB
Mefenamic Acid 250 mg + Dicyclomine Hydrochloride 10 mg
Manufactured at WHO-GMP certified facility by BIOFRIL HEALTHCARE. Available for hospital tender supply, ICU pharmacy, and PCD franchise distribution across India.
Product Specifications
SPASOZAB at a Glance
| Brand Name | SPASOZAB |
|---|---|
| Composition | Mefenamic Acid 250 mg + Dicyclomine Hydrochloride 10 mg |
| Therapeutic Category | Pain/NSAID |
| Division | General Oral/Topical |
| Pack / Presentation | Tab. 10X10 BLISTER |
| Manufacturer | BIOFRIL HEALTHCARE Pvt. Ltd. · WHO-GMP Plant, Nalagarh HP |
Clinical Use
Indications & Clinical Applications
SPASOZAB (Mefenamic Acid 250 mg + Dicyclomine Hydrochloride 10 mg) is indicated for the treatment of conditions in which Mefenamic Acid 250 mg therapy is clinically appropriate. For complete prescribing information please refer to the official product insert.